The presenilins are proteins of little known function which are involved in the etiology of Alzheimer's disease (AD). These proteins appear to be involved in development (particularly neural progenitor cell survival and neurogenesis), survival forms of apoptosis, and Abeta formation. There is evidence indicating that at least some of the effects of presenilins are mediated by the interaction of the COOH-terminus of these proteins with a cytoplasmic protein. For this reason, we have used the two-hybrid system to identify proteins interacting with the COOH- terminus of the presenilins and have found a novel protein which we call """"""""calsenilin"""""""". Our results indicate that the presenilins associate with calsenilin in situ and that calsenilin regulates the level of presenilin fragments. These data implicate calsenilin in the biology of the presenilins. Calsenilin is a novel member of the recovering family. Members of this family are calcium binding proteins which appear to play a role in modulating signaling transduction cascades in response to calcium signals. Our broad, long-term goal is to understand the normal function of the presenilins and to understand the molecular of their role in AD. As step towards this goal, we have identified a protein (calsenilin) which interacts with the domain of the presinilins which has been postulated as interacting with other proteins in order to exert biological effects. The next step would be to characterize the function of calsenilin, to study its role in presenilin-mediated effects, and to examine calsenilin in AD. From these studies, the role of calsenilin in presenilin biology and AD will be clarified. In the current proposal, we will take advantage of the unique resources of the ARDC to accomplish these goals.
The specific aims are as follows: 1. To localize calsenilin in the rat and primate nervous system. 2. To determine the relationship between the distribution of calsenilin, presenilin, neurofibrillary pathology, Abeta deposition, glutamatergic receptor subtypes and dying neurons in AD brain. 3. To characterize neural development of nice in which the calsenilin gene has been disrupted. 4. To characterize presenilin levels, Abeta formation and Abeta accumulation in mice in which the calsenilin gene has been disrupted.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005138-17
Application #
6312667
Study Section
Project Start
2000-05-15
Project End
2001-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
17
Fiscal Year
2000
Total Cost
$248,655
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Girdhar, Kiran; Hoffman, Gabriel E; Jiang, Yan et al. (2018) Cell-specific histone modification maps in the human frontal lobe link schizophrenia risk to the neuronal epigenome. Nat Neurosci 21:1126-1136
Huang, Qian; Voloudakis, Georgios; Ren, Yimin et al. (2018) Presenilin1/?-secretase protects neurons from glucose deprivation-induced death by regulating miR-212 and PEA15. FASEB J 32:243-253
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Giambartolomei, Claudia; Zhenli Liu, Jimmy; Zhang, Wen et al. (2018) A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34:2538-2545
Hauberg, Mads E; Fullard, John F; Zhu, Lingxue et al. (2018) Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls. Mol Psychiatry :
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71
Agrawal, A; Chou, Y-L; Carey, C E et al. (2018) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry 23:1293-1302

Showing the most recent 10 out of 555 publications